{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T20:02:18Z","timestamp":1760385738089,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Reserach and Care, Wessex"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Most clinical contacts with chronic obstructive pulmonary disease (COPD) patients take place in primary care, presenting opportunity for proactive clinical management. Electronic health records could be used to risk stratify diagnosed patients in this setting, but may be limited by poor data quality or completeness. We developed a risk stratification database algorithm using the DOSE index (Dyspnoea, Obstruction, Smoking and Exacerbation) with routinely collected primary care data, aiming to calculate up to three repeated risk scores per patient over five years, each separated by at least one year. Among 10,393 patients with diagnosed COPD, sufficient primary care data were present to calculate at least one risk score for 77.4%, and the maximum of three risk scores for 50.6%. Linked secondary care data revealed primary care under-recording of hospital exacerbations, which translated to a slight, non-significant cohort average risk score reduction, and an understated risk group allocation for less than 1% of patients. Algorithmic calculation of the DOSE index is possible using primary care data, and appears robust to the absence of linked secondary care data, if unavailable. The DOSE index appears a simple and practical means of incorporating risk stratification into the routine primary care of COPD patients, but further research is needed to evaluate its clinical utility in this setting. Although secondary analysis of routinely collected primary care data could benefit clinicians, patients and the health system, standardised data collection and improved data quality and completeness are also needed.<\/jats:p>","DOI":"10.1038\/s41533-019-0154-6","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T11:03:29Z","timestamp":1575457409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Primary care risk stratification in COPD using routinely collected data: a secondary data analysis"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5597-6615","authenticated-orcid":false,"given":"Matthew","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Rigge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1663-0253","authenticated-orcid":false,"given":"David","family":"Culliford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7157-2992","authenticated-orcid":false,"given":"Lynn","family":"Josephs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5939-1155","authenticated-orcid":false,"given":"Mike","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"154_CR1","unstructured":"Baxter N. et al. COPD in England \u2013 Finding the Measure of Success. National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Primary Care Report for England 2014\u201315 (RCP, 2016)."},{"key":"154_CR2","unstructured":"NHS RightCare. The NHS Atlas of Variation in Healthcare http:\/\/fingertips.phe.org.uk\/profile\/atlas-of-variation (2015)."},{"key":"154_CR3","unstructured":"National Health Service. Five Year Forward View https:\/\/www.england.nhs.uk\/ourwork\/futurenhs\/ (2014)."},{"key":"154_CR4","unstructured":"National Health Service. Next Steps On the NHS Five Year Forward View https:\/\/www.england.nhs.uk\/five-year-forward-view\/ (2017)."},{"key":"154_CR5","unstructured":"National Health Service. The NHS Long Term Plan https:\/\/www.longtermplan.nhs.uk\/publication\/nhs-long-term-plan\/ (2019)."},{"key":"154_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70015-8","volume":"1","author":"R Jones","year":"2013","unstructured":"Jones, R. et al. GOLD COPD categories are not fit for purpose in primary care. Lancet Respir. Med. 1, e17 (2013).","journal-title":"Lancet Respir. Med."},{"key":"154_CR7","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1365-2222.2005.02344.x","volume":"35","author":"AJ Wardlaw","year":"2005","unstructured":"Wardlaw, A. J., Silverman, M., Siva, R., Pavord, I. D. & Green, R. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin. Exp. Allergy 35, 1254\u20131262 (2005).","journal-title":"Clin. Exp. Allergy"},{"key":"154_CR8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021322","volume":"350","author":"BR Celli","year":"2004","unstructured":"Celli, B. R. et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 1005\u20131012 (2004).","journal-title":"N. Engl. J. Med."},{"key":"154_CR9","doi-asserted-by":"publisher","unstructured":"van Dijk W. D. et al. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir. Res. 12, https:\/\/doi.org\/10.1186\/1465-9921-12-151 (2011).","DOI":"10.1186\/1465-9921-12-151"},{"key":"154_CR10","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1164\/rccm.200902-0271OC","volume":"180","author":"RC Jones","year":"2009","unstructured":"Jones, R. C. et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am. J. Respir. Crit. Care Med. 180, 1189\u20131195 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"154_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/COPD.S42769","volume":"8","author":"T Motegi","year":"2013","unstructured":"Motegi, T. et al. A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations. Int. J. Chron. Obstruct. Pulmon. Dis. 8, 259\u2013271 (2013).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"154_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2147\/COPD.S24420","volume":"6","author":"T Oga","year":"2011","unstructured":"Oga, T., Tsukino, M., Hajiro, T., Ikeda, A. & Nishimura, K. Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 6, 521\u2013526 (2011).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"154_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4104\/pcrj.2012.00054","volume":"21","author":"J Sundh","year":"2012","unstructured":"Sundh, J., Janson, C., Lisspers, K., Stallberg, B. & Montgomery, S. The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD. Prim. Care Respir. J. 21, 295\u2013301 (2012).","journal-title":"Prim. Care Respir. J."},{"issue":"1","key":"154_CR14","doi-asserted-by":"publisher","first-page":"e12509","DOI":"10.1111\/ijn.12509","volume":"23","author":"Lan Wang","year":"2017","unstructured":"Wang, L. et al. Demographic, health behavioral, and self-management abilities associated with disease severity among patients with chronic obstructive pulmonary disease: an exploratory study. Int. J. Nurs. Pract. 23, e12509 (2017).","journal-title":"International Journal of Nursing Practice"},{"key":"154_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4104\/pcrj.2013.00033","volume":"22","author":"M Rolink","year":"2013","unstructured":"Rolink, M. et al. Using the DOSE index to predict changes in health status of patients with COPD: a prospective cohort study. Prim. Care Respir. J. 22, 169\u2013174 (2013).","journal-title":"Prim. Care Respir. J."},{"key":"154_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1183\/09031936.00121012","volume":"42","author":"JM Marin","year":"2013","unstructured":"Marin, J. M. et al. Multicomponent indices to predict survival in COPD: the COCOMICS study. Eur. Respir. J. 42, 323\u2013332 (2013).","journal-title":"Eur. Respir. J."},{"key":"154_CR17","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0140-6736(09)61301-5","volume":"374","author":"MA Puhan","year":"2009","unstructured":"Puhan, M. A. et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 374, 704\u2013711 (2009).","journal-title":"Lancet"},{"key":"154_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4104\/pcrj.2013.00050","volume":"22","author":"J Sundh","year":"2013","unstructured":"Sundh, J., Montgomery, S., Stallberg, B. & Lisspers, K. Assessment of COPD in primary care: new evidence supports use of the DOSE index. Prim. Care Respir. J. 22, 142\u2013143 (2013).","journal-title":"Prim. Care Respir. J."},{"key":"154_CR19","doi-asserted-by":"publisher","first-page":"1293386","DOI":"10.1080\/20018525.2017.1293386","volume":"4","author":"D Ryan","year":"2017","unstructured":"Ryan, D. et al. Use of electronic medical records and biomarkers to manage risk and resource efficiencies. Eur. Clin. Respir. J. 4, 1293386 (2017).","journal-title":"Eur. Clin. Respir. J."},{"key":"154_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/fampra\/cmu009","volume":"31","author":"S Muller","year":"2014","unstructured":"Muller, S. Electronic medical records: the way forward for primary care research? Fam. Pract. 31, 127\u2013129 (2014).","journal-title":"Fam. Pract."},{"key":"154_CR21","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1097\/MLR.0b013e31829b1dbd","volume":"51","author":"WR Hersh","year":"2013","unstructured":"Hersh, W. R. et al. Caveats for the use of operational electronic health record data in comparative effectiveness research. Med. Care 51, S30\u2013S37 (2013).","journal-title":"Med. Care"},{"key":"154_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2147\/CLEP.S117867","volume":"8","author":"KJ Rothnie","year":"2016","unstructured":"Rothnie, K. J. et al. Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records. Clin. Epidemiol. 8, 771\u2013782 (2016).","journal-title":"Clin. Epidemiol."},{"key":"154_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jclinepi.2016.01.005","volume":"75","author":"ER Millett","year":"2016","unstructured":"Millett, E. R., Quint, J. K., De Stavola, B. L., Smeeth, L. & Thomas, S. L. Improved incidence estimates from linked vs. stand-alone electronic health records. J. Clin. Epidemiol. 75, 66\u201369 (2016).","journal-title":"J. Clin. Epidemiol."},{"key":"154_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4104\/pcrj.2012.00066","volume":"21","author":"NH Chavannes","year":"2012","unstructured":"Chavannes, N. H., Jones, R. C., Postma, D. S. & Rennard, S. Using COPD multidimensional indices in routine clinical practice: DOSE meets all criteria. Prim. Care Respir. J. 21, 245\u2013246 (2012).","journal-title":"Prim. Care Respir. J."},{"key":"154_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/jamia\/ocw042","volume":"24","author":"BA Goldstein","year":"2017","unstructured":"Goldstein, B. A., Navar, A. M., Pencina, M. J. & Ioannidis, J. P. Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review. J. Am. Med. Inform. Assoc. 24, 198\u2013208 (2017).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"154_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12875-015-0223-z","volume":"16","author":"N Coleman","year":"2015","unstructured":"Coleman, N. et al. From patient care to research: a validation study examining the factors contributing to data quality in a primary care electronic medical record database. BMC Fam. Pract. 16, 11 (2015).","journal-title":"BMC Fam. Pract."},{"key":"154_CR27","unstructured":"Jordan, K. et al. Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases. Br. J. Gen. Pract. 57, 7\u201314 (2007)."},{"key":"154_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005540","volume":"4","author":"JK Quint","year":"2014","unstructured":"Quint, J. K. et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open 4, e005540 (2014).","journal-title":"BMJ Open"},{"key":"154_CR29","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"NF Khan","year":"2010","unstructured":"Khan, N. F., Harrison, S. E. & Rose, P. W. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br. J. Gen. Pract. 60, e128\u2013e136 (2010).","journal-title":"Br. J. Gen. Pract."},{"key":"154_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/amiajnl-2013-001847","volume":"21","author":"AR Tate","year":"2014","unstructured":"Tate, A. R. et al. Exploiting the potential of large databases of electronic health records for research using rapid search algorithms and an intuitive query interface. J. Am. Med. Inform. Assoc. 21, 292\u2013298 (2014).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"154_CR31","unstructured":"NHS Digital. Quality Outcomes Framework (QOF) https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/general-practice-data-hub\/quality-outcomes-framework-qof (2019)."},{"key":"154_CR32","unstructured":"NHS Digital. Quality and Outcomes Framework (QOF), Enhanced Services And Core Contract Extraction Specifications (Business Rules) https:\/\/digital.nhs.uk\/data-and-information\/data-collections-and-data-sets\/data-collections\/quality-and-outcomes-framework-qof (2019)."},{"key":"154_CR33","doi-asserted-by":"crossref","unstructured":"Rusanov, A., Weiskopf, N. G., Wang, S. & Weng C. Hidden in plain sight: bias towards sick patients when sampling patients with sufficient electronic health record data for research. BMC Med. Inform. Decis. Mak. 14, 51 (2014).","DOI":"10.1186\/1472-6947-14-51"},{"key":"154_CR34","first-page":"1472","volume":"2013","author":"NG Weiskopf","year":"2013","unstructured":"Weiskopf, N. G., Rusanov, A. & Weng, C. Sick patients have more data: the non-random completeness of electronic health records. AMIA Annu. Symp. Proc. 2013, 1472\u20131477 (2013).","journal-title":"AMIA Annu. Symp. Proc."},{"key":"154_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151357","volume":"11","author":"KJ Rothnie","year":"2016","unstructured":"Rothnie, K. J. et al. Validation of the recording of acute exacerbations of COPD in UK primary care electronic healthcare records. PLoS ONE 11, e0151357 (2016).","journal-title":"PLoS ONE"},{"key":"154_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006171","volume":"4","author":"H M\u00fcllerov\u00e1","year":"2014","unstructured":"M\u00fcllerov\u00e1, H., Shukla, A., Hawkins, A. & Quint, J. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open 4, e006171 (2014).","journal-title":"BMJ Open"},{"key":"154_CR37","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.jbi.2013.06.010","volume":"46","author":"NG Weiskopf","year":"2013","unstructured":"Weiskopf, N. G., Hripcsak, G., Swaminathan, S. & Weng, C. Defining and measuring completeness of electronic health records for secondary use. J. Biomed. Inf. 46, 830\u2013836 (2013).","journal-title":"J. Biomed. Inf."},{"key":"154_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.14236\/jhi.v19i3.811","volume":"19","author":"T Benson","year":"2011","unstructured":"Benson, T. The history of the Read codes: the inaugural James Read Memorial Lecture 2011. J. Innov. Health Inform. 19, 173\u2013182 (2011).","journal-title":"J. Innov. Health Inform."},{"key":"154_CR39","unstructured":"NHS Digital. Secondary Uses Service (SUS) http:\/\/content.digital.nhs.uk\/sus (2018)."},{"key":"154_CR40","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1378\/chest.08-1680","volume":"136","author":"TW Effing","year":"2009","unstructured":"Effing, T. W. et al. Definitions of exacerbations: does it really matter in clinical trials on COPD? Chest 136, 918\u2013923 (2009).","journal-title":"Chest"},{"key":"154_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/thoraxjnl-2011-200768","volume":"67","author":"SD Aaron","year":"2012","unstructured":"Aaron, S. D. et al. Time course and pattern of COPD exacerbation onset. Thorax 67, 238\u2013243 (2012).","journal-title":"Thorax"},{"key":"154_CR42","unstructured":"Department for Communities and Local Government. The English Indices of Deprivation 2015: Statistical Release https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015 (2015)."},{"key":"154_CR43","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2019 Report https:\/\/goldcopd.org\/ (2019)."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-019-0154-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-019-0154-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-019-0154-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T02:59:21Z","timestamp":1671245961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-019-0154-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["154"],"URL":"https:\/\/doi.org\/10.1038\/s41533-019-0154-6","relation":{},"ISSN":["2055-1010"],"issn-type":[{"type":"electronic","value":"2055-1010"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"30 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.J., L.R., D.C., L.J. and M.T. have no competing interests to declare. T.W. reports grants and support from AstraZeneca, GSK, Synairgen and My MHealth, and support from Chiesi and Boehringer Ingelheim during the conduct of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}